Financial Ratios Shenzhen YHLO Biotech Co., Ltd.
Equities
688575
CNE100005204
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.39 CNY | +0.42% |
|
+1.55% | +1.34% |
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
Profitability | |||||||
Return on Assets | 12.25 | 7.6 | 22.56 | 3.36 | 5.1 | ||
Return on Total Capital | 15.14 | 9.31 | 30.7 | 4.48 | 6.26 | ||
Return On Equity % | 30.98 | 17.9 | 51.61 | 11.22 | 10.4 | ||
Return on Common Equity | 31.25 | 17.85 | 51.36 | 14.27 | 11.34 | ||
Margin Analysis | |||||||
Gross Profit Margin % | 58.93 | 55.49 | 51.34 | 53.77 | 64.2 | ||
SG&A Margin | 24.22 | 25.7 | 15.52 | 27.54 | 30.2 | ||
EBITDA Margin % | 30.39 | 25.81 | 32.25 | 19.37 | 28.58 | ||
EBITA Margin % | 23.8 | 18.43 | 29.06 | 11.47 | 17.82 | ||
EBIT Margin % | 23.54 | 17.88 | 28.79 | 10.5 | 16.68 | ||
Income From Continuing Operations Margin % | 20.82 | 17.31 | 25.66 | 13.6 | 13.53 | ||
Net Income Margin % | 21.07 | 17.38 | 25.43 | 17.29 | 14.99 | ||
Net Avail. For Common Margin % | 21.07 | 17.38 | 25.43 | 17.29 | 14.99 | ||
Normalized Net Income Margin | 13.93 | 10.9 | 17.64 | 14.14 | 11.53 | ||
Levered Free Cash Flow Margin | -2.81 | -10.38 | 21.49 | -47.06 | -10.11 | ||
Unlevered Free Cash Flow Margin | -1.98 | -9.79 | 21.63 | -46.87 | -9.73 | ||
Asset Turnover | |||||||
Asset Turnover | 0.83 | 0.68 | 1.25 | 0.51 | 0.49 | ||
Fixed Assets Turnover | 2.56 | 2.15 | 4.64 | 1.7 | 1.3 | ||
Receivables Turnover (Average Receivables) | 4.85 | 4.84 | 13.08 | 5.31 | 4.21 | ||
Inventory Turnover (Average Inventory) | 1.45 | 1.58 | 4.15 | 1.58 | 1.1 | ||
Short Term Liquidity | |||||||
Current Ratio | 1.53 | 2.3 | 1.63 | 2.2 | 1.9 | ||
Quick Ratio | 0.87 | 1.48 | 1.2 | 1.39 | 1.22 | ||
Operating Cash Flow to Current Liabilities | 0.54 | 0.51 | 1.03 | -0.09 | 0.5 | ||
Days Sales Outstanding (Average Receivables) | 75.51 | 75.35 | 27.9 | 68.77 | 86.97 | ||
Days Outstanding Inventory (Average Inventory) | 252.65 | 230.44 | 87.94 | 231.53 | 331.72 | ||
Average Days Payable Outstanding | 53.44 | 65.38 | 37.93 | 92.07 | 100.88 | ||
Cash Conversion Cycle (Average Days) | 274.72 | 240.41 | 77.91 | 208.23 | 317.82 | ||
Long Term Solvency | |||||||
Total Debt/Equity | 41.21 | 15.43 | 19.37 | 22.01 | 33.53 | ||
Total Debt / Total Capital | 29.18 | 13.37 | 16.23 | 18.04 | 25.11 | ||
LT Debt/Equity | 1.06 | 5.16 | 7.74 | 15.21 | 21.76 | ||
Long-Term Debt / Total Capital | 0.75 | 4.47 | 6.48 | 12.47 | 16.29 | ||
Total Liabilities / Total Assets | 42.27 | 29.17 | 41.95 | 33.43 | 38.81 | ||
EBIT / Interest Expense | 17.85 | 18.77 | 136.31 | 34.47 | 27.53 | ||
EBITDA / Interest Expense | 23.05 | 27.45 | 153.31 | 65.64 | 47.64 | ||
(EBITDA - Capex) / Interest Expense | 8.67 | -5.76 | 86.06 | -40.33 | -1.05 | ||
Total Debt / EBITDA | 1.04 | 0.76 | 0.37 | 1.36 | 1.56 | ||
Net Debt / EBITDA | 0.27 | -0.85 | -0.74 | -0.37 | 0.33 | ||
Total Debt / (EBITDA - Capex) | 2.76 | -3.62 | 0.65 | -2.21 | -70.63 | ||
Net Debt / (EBITDA - Capex) | 0.72 | 4.04 | -1.33 | 0.61 | -14.73 | ||
Growth Over Prior Year | |||||||
Total Revenues, 1 Yr. Growth % | 13.87 | 17.91 | 237.95 | -48.42 | -2.02 | ||
Gross Profit, 1 Yr. Growth % | 34.9 | 15.67 | 215.53 | -45.98 | 16.98 | ||
EBITDA, 1 Yr. Growth % | 69.25 | -8.61 | 313.88 | -69.18 | 30.4 | ||
EBITA, 1 Yr. Growth % | 80 | -18.67 | 427.78 | -79.67 | 30.95 | ||
EBIT, 1 Yr. Growth % | 81.51 | -20 | 443.48 | -81.19 | 33.32 | ||
Earnings From Cont. Operations, 1 Yr. Growth % | 96.04 | -1.98 | 401.12 | -72.66 | -2.51 | ||
Net Income, 1 Yr. Growth % | 95.76 | -2.75 | 394.46 | -64.92 | -15.06 | ||
Normalized Net Income, 1 Yr. Growth % | 93.2 | -16.57 | 446.64 | -58.65 | -25.05 | ||
Diluted EPS Before Extra, 1 Yr. Growth % | 93.33 | -8.62 | 368.42 | -65.17 | -14.54 | ||
Accounts Receivable, 1 Yr. Growth % | 16.22 | 19.11 | 36.14 | 19.58 | 26.48 | ||
Inventory, 1 Yr. Growth % | 11.12 | 22.01 | 56.55 | 11.41 | 5.72 | ||
Net Property, Plant and Equip., 1 Yr. Growth % | 19.83 | 58 | 55.3 | 31.4 | 26.51 | ||
Total Assets, 1 Yr. Growth % | 23.04 | 61.51 | 97 | -9.67 | 16 | ||
Tangible Book Value, 1 Yr. Growth % | 34 | 94.24 | 54.8 | 7.45 | 8.6 | ||
Common Equity, 1 Yr. Growth % | 32.51 | 98.71 | 58.39 | 5.91 | 7.7 | ||
Cash From Operations, 1 Yr. Growth % | 312.87 | -7.99 | 509.8 | -104.62 | -824.03 | ||
Capital Expenditures, 1 Yr. Growth % | 47.86 | 96.77 | 51.71 | 17.22 | -10.47 | ||
Levered Free Cash Flow, 1 Yr. Growth % | -80.51 | 1.06K | -800.72 | -212.93 | -78.46 | ||
Unlevered Free Cash Flow, 1 Yr. Growth % | -85.09 | 4.97K | -847.99 | -211.78 | -79.18 | ||
Dividend Per Share, 1 Yr. Growth % | - | - | 57.51 | -39.33 | -23.08 | ||
Compound Annual Growth Rate Over Two Years | |||||||
Total Revenues, 2 Yr. CAGR % | 17.09 | 15.87 | 99.62 | 32.02 | -28.91 | ||
Gross Profit, 2 Yr. CAGR % | 44.19 | 22.39 | 90.18 | 30.56 | -20.51 | ||
EBITDA, 2 Yr. CAGR % | 100.7 | 30.2 | 96.43 | 13.24 | -33.26 | ||
EBITA, 2 Yr. CAGR % | 113.72 | 28.2 | 108.2 | 3.67 | -44.39 | ||
EBIT, 2 Yr. CAGR % | 117.78 | 27.49 | 108.65 | 1.11 | -45.89 | ||
Earnings From Cont. Operations, 2 Yr. CAGR % | 133.83 | 38.62 | 121.63 | 17.03 | -48.37 | ||
Net Income, 2 Yr. CAGR % | 135.28 | 37.98 | 119.29 | 31.68 | -45.42 | ||
Normalized Net Income, 2 Yr. CAGR % | 125.27 | 33.54 | 113.56 | 50.34 | -42.52 | ||
Diluted EPS Before Extra, 2 Yr. CAGR % | 129.59 | 32.92 | 107.28 | 27.73 | -45.44 | ||
Accounts Receivable, 2 Yr. CAGR % | 17.5 | 17.66 | 27.34 | 27.59 | 22.98 | ||
Inventory, 2 Yr. CAGR % | 21.06 | 16.44 | 38.21 | 32.06 | 8.52 | ||
Net Property, Plant and Equip., 2 Yr. CAGR % | 20.81 | 37.63 | 56.65 | 42.85 | 28.93 | ||
Total Assets, 2 Yr. CAGR % | 25.64 | 40.98 | 78.37 | 33.43 | 2.36 | ||
Tangible Book Value, 2 Yr. CAGR % | 56.55 | 61.33 | 73.4 | 28.98 | 8.02 | ||
Common Equity, 2 Yr. CAGR % | 51.88 | 62.27 | 77.41 | 29.53 | 6.81 | ||
Cash From Operations, 2 Yr. CAGR % | 208.18 | 94.91 | 136.87 | -46.91 | -42.15 | ||
Capital Expenditures, 2 Yr. CAGR % | 0.8 | 70.57 | 72.78 | 33.35 | 2.44 | ||
Levered Free Cash Flow, 2 Yr. CAGR % | - | -7.82 | 802.43 | 181.3 | -51.26 | ||
Unlevered Free Cash Flow, 2 Yr. CAGR % | - | -6.88 | 1.85K | 189.16 | -52.32 | ||
Dividend Per Share, 2 Yr. CAGR % | - | - | - | -2.25 | -31.69 | ||
Compound Annual Growth Rate Over Three Years | |||||||
Total Revenues, 3 Yr. CAGR % | - | 17.36 | 65.55 | 27.14 | 19.53 | ||
Gross Profit, 3 Yr. CAGR % | - | 32.16 | 67.31 | 25.01 | 25.87 | ||
EBITDA, 3 Yr. CAGR % | - | 59.2 | 92.71 | 6.13 | 22.84 | ||
EBITA, 3 Yr. CAGR % | - | 60.96 | 106.13 | -4.08 | 17.81 | ||
EBIT, 3 Yr. CAGR % | - | 61.94 | 106.81 | -6.44 | 16.74 | ||
Earnings From Cont. Operations, 3 Yr. CAGR % | - | 75 | 112.75 | 10.32 | 10.12 | ||
Net Income, 3 Yr. CAGR % | - | 75.26 | 111.15 | 19.03 | 13.77 | ||
Normalized Net Income, 3 Yr. CAGR % | - | 67.32 | 113.62 | 23.54 | 21.78 | ||
Diluted EPS Before Extra, 3 Yr. CAGR % | - | 68.88 | 102.52 | 14.38 | 11.72 | ||
Accounts Receivable, 3 Yr. CAGR % | - | 18.03 | 23.52 | 24.7 | 27.22 | ||
Inventory, 3 Yr. CAGR % | - | 21.38 | 28.52 | 28.63 | 22.62 | ||
Net Property, Plant and Equip., 3 Yr. CAGR % | - | 32.14 | 43.29 | 47.73 | 37.18 | ||
Total Assets, 3 Yr. CAGR % | - | 36.62 | 57.61 | 42.2 | 27.35 | ||
Tangible Book Value, 3 Yr. CAGR % | - | 68.22 | 59.13 | 47.84 | 21.79 | ||
Common Equity, 3 Yr. CAGR % | - | 66.12 | 60.97 | 49.39 | 21.8 | ||
Cash From Operations, 3 Yr. CAGR % | - | 105.98 | 185.07 | -36.23 | 26.85 | ||
Capital Expenditures, 3 Yr. CAGR % | - | 25.98 | 64.04 | 51.82 | 16.77 | ||
Levered Free Cash Flow, 3 Yr. CAGR % | - | - | 81.17 | 351.38 | 18.52 | ||
Unlevered Free Cash Flow, 3 Yr. CAGR % | - | - | 86.4 | 650.68 | 19.35 | ||
Dividend Per Share, 3 Yr. CAGR % | - | - | - | - | -9.75 | ||
Compound Annual Growth Rate Over Five Years | |||||||
Total Revenues, 5 Yr. CAGR % | - | - | - | 23.02 | 18.05 | ||
Gross Profit, 5 Yr. CAGR % | - | - | - | 31.28 | 24.24 | ||
EBITDA, 5 Yr. CAGR % | - | - | - | 39.47 | 26.23 | ||
EBITA, 5 Yr. CAGR % | - | - | - | 35.25 | 22.1 | ||
EBIT, 5 Yr. CAGR % | - | - | - | 34.17 | 20.96 | ||
Earnings From Cont. Operations, 5 Yr. CAGR % | - | - | - | 48.99 | 20.74 | ||
Net Income, 5 Yr. CAGR % | - | - | - | 56.32 | 22.9 | ||
Normalized Net Income, 5 Yr. CAGR % | - | - | - | 60.31 | 26.35 | ||
Diluted EPS Before Extra, 5 Yr. CAGR % | - | - | - | 51.14 | 19.85 | ||
Accounts Receivable, 5 Yr. CAGR % | - | - | - | 21.77 | 23.3 | ||
Inventory, 5 Yr. CAGR % | - | - | - | 25.54 | 20.11 | ||
Net Property, Plant and Equip., 5 Yr. CAGR % | - | - | - | 36.32 | 37.36 | ||
Total Assets, 5 Yr. CAGR % | - | - | - | 35.33 | 32.63 | ||
Tangible Book Value, 5 Yr. CAGR % | - | - | - | 51.26 | 36.29 | ||
Common Equity, 5 Yr. CAGR % | - | - | - | 50.38 | 36.61 | ||
Cash From Operations, 5 Yr. CAGR % | - | - | - | 19.76 | 50.63 | ||
Capital Expenditures, 5 Yr. CAGR % | - | - | - | 28.88 | 35.88 | ||
Levered Free Cash Flow, 5 Yr. CAGR % | - | - | - | - | 7.15 | ||
Unlevered Free Cash Flow, 5 Yr. CAGR % | - | - | - | - | 8.04 |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















